Largest pharmaceuticals by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceuticals ranked by earnings, at SEK 272.5B, ahead of Eli Lilly (SEK 209.9B) and Merck & Co (SEK 185.6B). Figures as of 18 Nov 2026, 15:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonSEK 272.5B
- Median
- SEK 600M
- Combined market value
- SEK 52.01T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SEK 272.5B | SEK 6.77T | SEK 2,811.18 | 0.80% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | SEK 209.9B | SEK 12.69T | SEK 14,241.38 | 1.06% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | SEK 185.6B | SEK 3.53T | SEK 1,432.08 | 1.76% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | SEK 154.6B | SEK 1.8T | SEK 407.53 | 1.53% down | 17% down | ||
| 5 | NovartisNVS · Health Care | SEK 142.2B | SEK 3.01T | SEK 1,593.65 | 1.51% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | SEK 104B | SEK 2.84T | SEK 1,828.43 | 1.34% down | 2% up | ||
| 7 | SanofiSNY · Health Care | SEK 88.1B | SEK 1.16T | SEK 482.23 | 0.22% down | 4% down | ||
| 8 | PfizerPFE · Health Care | SEK 79B | SEK 1.64T | SEK 287.91 | 0.54% down | 14% up | ||
| 9 | GSKGSK · Health Care | SEK 77.1B | SEK 1T | SEK 499.15 | 0.30% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | SEK 71.7B | SEK 1.25T | SEK 613.49 | 1.65% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | SEK 66.3B | SEK 1.84T | SEK 1,063.48 | 0.11% down | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | SEK 45.8B | SEK 1.01T | SEK 9,802.13 | 0.65% up | 36% up | ||
| 13 | AbbVieABBV · Health Care | SEK 43B | SEK 5.21T | SEK 2,945.02 | 1.09% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | SEK 40.2B | SEK 1.39T | SEK 5,476.05 | 0.81% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | SEK 27.2B | SEK 345.6B | SEK 850.46 | 0.19% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | SEK 14.3B | SEK 504.7B | SEK 432.55 | 0.19% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | SEK 13.6B | SEK 250.1B | SEK 5,872.60 | 1.12% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | SEK 9.8B | SEK 324.2B | SEK 525.84 | 0.47% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | SEK 7.8B | SEK 401.4B | SEK 698.04 | 0.04% down | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | SEK 6.9B | SEK 51.5B | SEK 616.90 | 0.51% up | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 4.6B | SEK 127.2B | SEK 152.57 | 1.39% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | SEK 4.5B | SEK 97.7B | SEK 646.18 | 1.34% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | SEK 4.5B | SEK 59.3B | SEK 87.20 | 0.63% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | SEK 3.5B | SEK 117.7B | SEK 607.75 | 2.15% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | SEK 3.2B | SEK 211B | SEK 1,575.15 | 1.02% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | SEK 2.9B | SEK 472.6B | SEK 4,136.98 | 1.55% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | SEK 2.5B | SEK 78.7B | SEK 468.60 | 1.40% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | SEK 1.3B | SEK 60.7B | SEK 3,036.86 | 1.65% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | SEK 1B | SEK 77.6B | SEK 708.62 | 0.54% down | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | SEK 732.7M | SEK 76.2B | SEK 218.72 | 1.85% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 600M | SEK 77.1B | SEK 981.33 | 1.47% up | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -SEK 16.6M | SEK 62.8B | SEK 444.45 | 1.67% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -SEK 237.6M | SEK 60.8B | SEK 931.30 | 0.39% down | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -SEK 259.8M | SEK 49.3B | SEK 514.10 | 1.06% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -SEK 711.7M | SEK 54.2B | SEK 1,285.35 | 0.61% up | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -SEK 789.2M | SEK 65.5B | SEK 1,612.82 | 0.57% up | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -SEK 1.1B | SEK 67.5B | SEK 994.75 | 1.57% up | 241% up | ||
| 38 | ErascaERAS · Health Care | -SEK 1.3B | SEK 48.2B | SEK 137.22 | 2.84% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -SEK 1.3B | SEK 84.3B | SEK 1,291.05 | 1.84% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -SEK 1.6B | SEK 92.6B | SEK 974.62 | 2.17% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -SEK 1.7B | SEK 50.1B | SEK 889.05 | 0.52% up | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -SEK 1.7B | SEK 46.4B | SEK 423.50 | 0.93% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -SEK 1.9B | SEK 72B | SEK 1,369.14 | 0.96% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -SEK 1.9B | SEK 40.8B | SEK 297.82 | 0.31% down | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -SEK 2B | SEK 82.7B | SEK 1,192.52 | 0.57% up | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -SEK 2.4B | SEK 133.8B | SEK 267.78 | 1.88% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -SEK 2.6B | SEK 179.7B | SEK 2,739.85 | 0.64% down | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -SEK 2.9B | SEK 98.4B | SEK 4,234.01 | 1.32% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -SEK 3B | SEK 32.2B | SEK 166.10 | 1.40% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -SEK 3B | SEK 286.9B | SEK 395.95 | 0.59% up | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -SEK 3.1B | SEK 87.6B | SEK 3,135.14 | 1.07% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -SEK 3.3B | SEK 50.7B | SEK 291.42 | 2.91% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -SEK 3.6B | SEK 158.6B | SEK 2,471.06 | 0.96% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -SEK 3.8B | SEK 74.8B | SEK 854.53 | 2.36% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -SEK 3.9B | SEK 45.8B | SEK 274.95 | 0.30% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -SEK 7.5B | SEK 153.8B | SEK 789.45 | 1.09% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -SEK 8B | SEK 73.9B | SEK 530.67 | 1.05% up | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -SEK 9.7B | SEK 697.3B | SEK 218.27 | 0.80% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -SEK 11B | SEK 90.4B | SEK 113.07 | 4.22% up | 36% down | ||
| 60 | InsmedINSM · Health Care | -SEK 13B | SEK 270.1B | SEK 1,231.00 | 0.65% down | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -SEK 35.7B | SEK 240.4B | SEK 209.67 | 0.83% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1681 SEK).
Questions and answers
Which pharmaceuticals rank first by earnings?
Johnson & Johnson (SEK 272.5B), Eli Lilly (SEK 209.9B) and Merck & Co (SEK 185.6B) are the top three of the 61 pharmaceuticals ranked by earnings as of 18 Nov 2026, 15:14 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by earnings.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by earnings have a combined market value of SEK 52.01T as of 18 Nov 2026, 15:14 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceuticals by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.